Warren Buffett disciple Guy Spier built career on value investing. A rare cancer changed everything
RSS SUMMARY · AGGREGATED FROM CNBC
After a glioblastoma diagnosis, value investor Guy Spier rethought wealth, time and legacy — and the impact he can have on rare disease research.
After a glioblastoma diagnosis, value investor Guy Spier rethought wealth, time and legacy — and the impact he can have on rare disease research.
After a glioblastoma diagnosis, value investor Guy Spier rethought wealth, time and legacy — and the impact he can have on rare disease research.
Continue Reading
The full story continues on CNBC.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
CNBC
US
The Tech Download: Anthropic’s IPO sets up first big test of AI boom valuations
CNBC·1h ago·3 min read
Business
Broadway’s $1.9 billion season is the latest sign of consumers splurging on experiences
CNBC·31m ago·3 min read
Business
Family offices bet on sports, from pickleball leagues to smart soccer balls
CNBC·31m ago·3 min read
Business
Lululemon cuts annual outlook, citing ‘negative’ media commentary and disappointing product launches
CNBC·15h ago·3 min read
Related